Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M801657200 on June 12, 2008

J. Biol. Chem., Vol. 283, Issue 40, 27289-27299, October 3, 2008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
283/40/27289    most recent
M801657200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Unno, H.
Right arrow Articles by Kusunoki, M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Unno, H.
Right arrow Articles by Kusunoki, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Structural Basis for Substrate Recognition and Hydrolysis by Mouse Carnosinase CN2*Formula

Hideaki Unno12, Tetsuo Yamashita13, Sayuri Ujita4, Nobuaki Okumura5, Hiroto Otani, Akiko Okumura, Katsuya Nagai6, and Masami Kusunoki7

From the Institute for Protein Research, Osaka University, 3-2 Yamadaoka, Suita, Osaka 565-0871, Japan

L-Carnosine is a bioactive dipeptide (β-alanyl-L-histidine) present in mammalian tissues, including the central nervous system, and has potential neuroprotective and neurotransmitter functions. In mammals, two types of L-carnosine-hydrolyzing enzymes (CN1 and CN2) have been cloned thus far, and they have been classified as metallopeptidases of the M20 family. The enzymatic activity of CN2 requires Mn2+, and CN2 is inhibited by a nonhydrolyzable substrate analog, bestatin. Here, we present the crystal structures of mouse CN2 complexed with bestatin together with Zn2+ at a resolution of 1.7Å and that with Mn2+ at 2.3Å. CN2 is a homodimer in a noncrystallographic asymmetric unit, and the Mn2+ and Zn2+ complexes closely resemble each other in the overall structure. Each subunit is composed of two domains: domain A, which is complexed with bestatin and two metal ions, and domain B, which provides the major interface for dimer formation. The bestatin molecule bound to domain A interacts with several residues of domain B of the other subunit, and these interactions are likely to be essential for enzyme activity. Since the bestatin molecule is not accessible to the bulk water, substrate binding would require conformational flexibility between domains A and B. The active site structure and substrate-binding model provide a structural basis for the enzymatic activity and substrate specificity of CN2 and related enzymes.


Received for publication, February 29, 2008 , and in revised form, May 27, 2008.

The atomic coordinates and structure factors (codes 2ZOF and 2ZOG) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (http://www.rcsb.org/).

* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Formula The on-line version of this article (available at http://www.jbc.org) contains supplemental Figs. S1-S6.

1 Both authors contributed equally to this work.

2 Present address: Dept. of Applied Chemistry, Faculty of Engineering, Nagasaki University, 1-14 Bunkyo-machi, Nagasaki, 852-8521, Japan.

3 Present address: Japan Tobacco Inc., Pharmaceutical Frontier Research Laboratories, 1-13-2, Fukuura, Kanazawa-ku, Yokohama, Kanagawa 236-0004, Japan.

4 Present address: P&G K.K. Takasaki Plant, 321 Yawata-machi Takasaki, Gunma 370-0884, Japan.

6 Present address: ANBAS Corp., Nakajima Bldg., 4-12-17 Toyosaki, Kita-ku, Osaka, Osaka 531-0072, Japan.

5 To whom correspondence may be addressed: Laboratory of Homeostatic Integration, Division of Integrated Protein Functions, Institute for Protein Research, Osaka University, 3-2 Yamadaoka, Suita, Osaka 565-0871, Japan. Tel.: 81-6-6879-8632; Fax: 81-6-6879-8633; E-mail: nokumura{at}protein.osaka-u.ac.jp.

7 To whom correspondence may be addressed: Dept. of Biotechnology, Faculty of Engineering, University of Yamanashi, 4-3-11 Takeda, Kofu City, Yamanashi 400-8511, Japan. Tel./Fax: 81-55-220-8537; E-mail: mkusunoki{at}yamanashi.ac.jp.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement